Form 4: Cognition Therapeutics Director Acquires Shares and Options

Director Brett P. Monia acquired 8,500 shares of common stock and options to purchase 8,500 shares of Cognition Therapeutics stock on June 7, 2024.

Summary

• On June 7, 2024, Brett P. Monia, a director of Cognition Therapeutics Inc. (CGTX), acquired 8,500 shares of common stock represented by restricted stock units (RSUs) and options to purchase 8,500 shares of common stock.
• The RSUs and options vest in full on the earlier of June 7, 2025, or the date of the Issuer's next annual meeting of stockholders, contingent upon continuous service as a director.
• The price of the acquired common stock was $0.00, and the exercise price of the stock options is $1.95.
• Following the transaction, Monia directly owns 14,500 shares of common stock and 8,500 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares and options can be seen as a positive sign, but it's a routine transaction.

Positives

• A director's acquisition of shares and options may signal confidence in the company's future prospects.

Future Outlook

The vesting of the RSUs and options is contingent upon the director's continuous service, suggesting an incentive for continued involvement with the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Comparing the vesting schedule and option terms to those of similar biotech companies would provide context on whether these incentives are standard or particularly generous.
• Analyzing the director's total holdings relative to other insiders and institutional investors could offer insights into the level of alignment between management and shareholders.
• Comparing the option exercise price to the current market price of CGTX stock would indicate the potential value of the options to the director.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders if it signals confidence from a company director.
• The vesting conditions of the RSUs and options incentivize the director to remain engaged with the company, potentially benefiting all stakeholders.

Key Dates